UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
(Check one): Form 10-K Form 20-F X Form 10-Q Form N-SAR
--- --- ----- ---
For period ended: June 30, 1998
------------------
[ ] Transition Report on Form 10-K and Form 10-KSB
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q and Form 10-QSB
[ ] Transition Report on Form N-SAR
For the transition period ended___________________________
SEC File Number 0-11472
-----------
CUSIP Number - 09061T509
-----------
Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.
If the notification relates to a portion of the filing checked above,
identify the item(s) to which the notification
relates:__________________________
PART I-REGISTRANT INFORMATION
BIOMUNE SYSTEMS, INC.
- --------------------------------------
Full Name of Registrant
2401 South Foothill Dr.
Salt Lake City, Utah 84109
(801) 466-3441
- --------------------------------------
Address and telephone number of
principal executive office
PART II-RULES 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed. (Check appropriate box)
[X] (a) The reasons described in reasonable detail in Part III of this
form could not be eliminated without unreasonable effort or
expense;
[X] (b) The subject annual report, semi-annual report, transition
report on Forms 10-K, 10-KSB, 20-F, 11-K, or Form N-SAR, or
portion thereof will be filed on or before the 15th calendar
day following the prescribed due date; or the subject quarterly
report or transition report on Form 10-Q, 10-QSB, or portion
thereof will be filed on or before the fifth calendar day
following the prescribed due date; and
[ ] (c) The accountant's statement or other exhibit required by Rule
12b-25(c) has been attached if applicable.
<PAGE>
PART III-NARRATIVE
State below in reasonable detail the reasons why the Form 10-K, 10-
KSB, 11-K, 20-F 10-Q, 10-QSB, N-SAR or the transition report portion
thereof, could not be filed within the prescribed time period.
The quarterly report of the registrant on Form 10-Q for the
quarterly period ended June 30, 1998 could not be filed because
of delays encountered in finalizing the financial and other
information needed to complete the report as it relates to the
registrant's on-going efforts to finalize the terms of the
Rockwood Cosmetics, Inc. transaction.
PART IV-OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification.
Michael G. Acton, President (801) 466-3441
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under Section 13 or 15(d) or
the Securities Exchange Act of 1934 or Section 30 of the Investment
Company Act of 1940 during the preceding 12 months (or for such
shorter period that the registrant was required to file such
report(s)) been filed? If the answer is no, identify report(s).
X Yes __ No
(3) Is it anticipated that any significant change in results of
operations from the corresponding period for the last fiscal year
will be reflected by the earnings statements to be included in the
subject report or portion thereof?
___ Yes X No
If so: attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate, state the
reasons why a reasonable estimate of the results cannot be made.
BIOMUNE SYSTEMS, INC.
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Date: August 13, 1998 By: /s/ Michael G. Acton
---------------------------------
Michael G. Acton, President and
Chief Executive Officer
